DEXCOM, INC. Deferred Income Tax Liabilities, Net
DEXCOM, INC. (DXCM) had Deferred Income Tax Liabilities, Net of $4.60 million as of 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2023-10-26
- 2023-09-30: Deferred Income Tax Liabilities, Net $4.60M.
- 2023-06-30: Deferred Income Tax Liabilities, Net $4.80M.
- 2023-03-31: Deferred Income Tax Liabilities, Net $4.80M.
- 2022-12-31: Deferred Income Tax Liabilities, Net $4.90M.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2023-09-30 | $4.60M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $4.80M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $4.80M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $4.90M 10-Q · filed 2023-10-26 |
| 2022-09-30 | $5.30M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $5.60M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $6.10M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $5.90M 10-K · filed 2023-02-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |